A Comprehensive Grading System for a Magnetic Sentinel Lymph Node Biopsy Procedure in Head and Neck Cancer Patients.
Eliane R NieuwenhuisBarry KolenaarJurrit J HofJoop van BaarlenAlexander J M van BemmelAnke ChristenhuszTom W J ScheenenBernard Ten HakenRemco de BreeLejla AlicPublished in: Cancers (2022)
A magnetic sentinel lymph node biopsy ((SLN)B) procedure has recently been shown feasible in oral cancer patients. However, a grading system is absent for proper identification and classification, and thus for clinical reporting. Based on data from eight complete magnetic SLNB procedures, we propose a provisional grading system. This grading system includes: (1) a qualitative five-point grading scale for MRI evaluation to describe iron uptake by LNs; (2) an ex vivo count of resected SLN with a magnetic probe to quantify iron amount; and (3) a qualitative five-point grading scale for histopathologic examination of excised magnetic SLNs. Most SLNs with iron uptake were identified and detected in level II. In this level, most variance in grading was seen for MRI and histopathology; MRI and medullar sinus were especially highly graded, and cortical sinus was mainly low graded. On average 82 ± 58 µg iron accumulated in harvested SLNs, and there were no significant differences in injected tracer dose (22.4 mg or 11.2 mg iron). In conclusion, a first step was taken in defining a comprehensive grading system to gain more insight into the lymphatic draining system during a magnetic SLNB procedure.
Keyphrases
- sentinel lymph node
- lymph node
- molecularly imprinted
- magnetic resonance imaging
- neoadjuvant chemotherapy
- contrast enhanced
- minimally invasive
- end stage renal disease
- newly diagnosed
- ejection fraction
- machine learning
- prognostic factors
- chronic kidney disease
- squamous cell carcinoma
- computed tomography
- diffusion weighted imaging
- ultrasound guided
- mass spectrometry
- patient reported outcomes
- living cells
- high resolution
- solid phase extraction
- rectal cancer
- adverse drug